CNS|CRO offers a new approach to solving neurological diseases using unique animal models that more accurately reflect the progression of neurological disease in humans. Designed to be a preferred provider of pre-clinical contract research, our team functions as an independent extension of your pre-clinical process. CNS|CRO provides its clients with focus, expertise and a quality customer experience with services that are flexible and innovative.
A wholly-owned subsidiary of Neurodyn Inc, CNS|CRO is a pre-clinical contract research organization offering a suite of animal models of neurological disease that are:
- slowly developing and progressive
- environmentally based
- highly predictive
- ideal for identification of early stage treatments.
Neurological disease is a large and growing problem – despite billions of research dollars, the causes of most neurological disease are still not fully understood. For the most part treatments only help to alleviate symptoms and ‘standard’ animal models are often quite limited, with many replicating only one aspect of the disease process as identified in a small minority of patients. Successful drug development programs require animal models that more faithfully replicate the human disease condition. CNS|CRO is pleased to offer these highly predictive models.
In addition, CNS|CRO offers a variety of behavioural tests for animal model assessment. Each test is adaptable, and our experienced team will work with you to design a testing regime tailored to suit your specific needs.